Edition:
United Kingdom

People: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

377.40INR
5:00am BST
Change (% chg)

Rs3.35 (+0.90%)
Prev Close
Rs374.05
Open
Rs371.25
Day's High
Rs378.60
Day's Low
Rs371.25
Volume
110,632
Avg. Vol
1,181,517
52-wk High
Rs705.90
52-wk Low
Rs353.50

Saldanha, Glenn 

Mr. Glenn Mario Saldanha serves as Executive Chairman of the Board, Chief Executive Officer, Managing Director of Glenmark Pharmaceuticals Ltd. Mr. Saldanha joined Glenmark in 1998 as Director and took over as Managing Director & CEO in 2000. He transformed Glenmark into a truly global organisation with revenue over a billion dollar. Under his leadership, Glenmark has evolved from an Indian branded generics business into a research-driven and innovation-led organisation. Mr. Saldanha’s vision is to discover, develop and take to market India's first innovative drug for the entire world.

Basic Compensation

Total Annual Compensation, INR 149,100,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR 12,520,000
Fiscal Year Total, INR 161,620,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Glenn Saldanha

161,620,000

V. S. Mani

21,140,000

Harish Kuber

2,750,000

Cherylann Pinto

42,940,000

Rajesh Desai

1,200,000

Blanche Saldanha

400,000
As Of  31 Mar 2018